Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review

References

• AhmedM2006Management of intermittent angle closure glaucoma with Nd: YAG laser iridotomy as a primary procedureJ Coll Physicians Surg Pak16764717125635
   PubMedGoogle Scholar
• AlmA1995Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study GroupOphthalmology1021743529098273
   PubMed Web of Science ®Google Scholar
• ArdjomandN2000Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasoneEye143758311027004
   PubMed Web of Science ®Google Scholar
• AungT2005Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucomaOphthalmology1122677115691562
   PubMed Web of Science ®Google Scholar
• AungT2000Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary studyOphthalmology10711788310857840
   PubMed Web of Science ®Google Scholar
• BaudouinC2007In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprostInvest Ophthalmol Vis Sci484123817724196
   PubMed Web of Science ®Google Scholar
• BucciMG1999Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study GroupJ Glaucoma8243010084271
   PubMed Web of Science ®Google Scholar
• CamrasCB1996Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. United States Latanoprost Study GroupOphthalmology103138478628544
   PubMed Web of Science ®Google Scholar
• CelliniM2004Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter studyOphthalmologica218312715334011
   PubMed Web of Science ®Google Scholar
• ChenMJ2007Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucomaJ Ocul Pharmacol Ther235596618001247
   PubMed Web of Science ®Google Scholar
• ChenMJ2006Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucomaJ Ocul Pharmacol Ther224495417238812
   PubMed Web of Science ®Google Scholar
• ChewPT2004Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucomaOphthalmology1114273415019314
   PubMed Web of Science ®Google Scholar
• ClarkAF1995Steroids, ocular hypertension and glaucomaJ Glaucoma435469
   PubMedGoogle Scholar
• CrawfordK1987Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alphaArch Ophthalmol105111263477218
   PubMed Web of Science ®Google Scholar
• DasguptaS2002Population-based persistency rates for topical glaucoma medications measured with pharmacy claims dataAm J Manag Care810 SupplS2556112188168
   PubMed Web of Science ®Google Scholar
• De Saint JeanM1999Effects of benzalkonium chloride on growth and survival of Chang conjunctival cellsInvest Ophthalmol Vis Sci406193010067965
   PubMed Web of Science ®Google Scholar
• DuBinerH2001Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprostSurv Ophthalmol45Suppl 4S3536011434938
   PubMed Web of Science ®Google Scholar
• DutkiewiczR2000Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma linesExp Eye Res70563910870514
   PubMed Web of Science ®Google Scholar
• FungAT2007Meta-analysis of randomised controller trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucomaBr J Ophthalmology91628
   PubMed Web of Science ®Google Scholar
• GandolfiS2001Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertensionAdv Ther181102111571823
   PubMed Web of Science ®Google Scholar
• García SanchezJ2000Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension – a three-month randomised study. Spanish Latanoprost Study GroupEur J Ophthalmol1019820411071026
   PubMed Web of Science ®Google Scholar
• GherghelD2008First-line therapy with latanoprost 0.005% results in improved ocular circulation in newly diagnosed primary open-angle glaucoma patients: a prospective, 6-month, open-label studyEye22363917115020
   PubMed Web of Science ®Google Scholar
• GuptaSK2007Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucomaMethods Find Exp Clin Pharmacol296657118200329
   PubMedGoogle Scholar
• HarrisA2008The effect of latanoprost on ocular blood flowInt Ophthalmol Feb 23 [Epub ahead of print]
   Google Scholar
• HedmanK2000A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timololEur J Ophthalmol109510410887918
   PubMed Web of Science ®Google Scholar
• HigginbothamEJ2002Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trialArch Ophthalmol1209152212096962
   PubMed Web of Science ®Google Scholar
• InoueK2006Adverse reaction after use of latanoprost in Japanese glaucoma patientsNippon Ganka Gakkai Zasshi110581716972649
   PubMedGoogle Scholar
• JohnstoneMA1997Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprostAm J Ophthalmol12454479323945
   PubMed Web of Science ®Google Scholar
• KahookMY2008Quantitative analysis of conjunctival goblet cells after chronic application of topical dropsAdv Ther257435118670744
   PubMed Web of Science ®Google Scholar
• KentAR1999Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertensionJ Glaucoma82576210464735
   PubMed Web of Science ®Google Scholar
• KozOG2007Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trialActa Ophthalmol Scand858384317680841
   PubMedGoogle Scholar
• LachaineJ2008Prostaglandin analogues for ophthalmic use: a cost-effectiveness analysisCan J Ophthalmol43334118219345
   PubMed Web of Science ®Google Scholar
• LeskeMC2002Incident open-angle glaucoma and blood pressureArch Ophthalmol1209545912096967
   PubMed Web of Science ®Google Scholar
• LeungEW2008Prevalence of ocular surface disease in glaucoma patientsJ Glaucoma17350518703943
   PubMed Web of Science ®Google Scholar
• LindenC1998Latanoprost twice daily is less effective then once daily: indication of receptor subsensitivity?Curr Eye Res17567729663846
   PubMed Web of Science ®Google Scholar
• LindénC1997Effects on IOP restoration and blood-aqueous barrier after long-term treatment with latanoprost in open angle glaucoma and ocular hypertensionBr J Ophthalmol8137029227201
   PubMed Web of Science ®Google Scholar
• MartinezA2007Retrobulbar haemodynamic effects of the latanoprost/timolol and the dorzolamide/timolol fixed combinations in newly diagnosed glaucoma patientsInt J Clin Pract618152517343668
   PubMed Web of Science ®Google Scholar
• MastropasquaL1999A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucomaOphthalmology106550510080213
   PubMed Web of Science ®Google Scholar
• LimKS2008Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover studyOphthalmology115790518452763
   PubMed Web of Science ®Google Scholar
• NagasubramanianS1993Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimensOphthalmology1001305118371916
   PubMed Web of Science ®Google Scholar
• NolanWP2000YAG laser iridotomy treatment for primary angle closure in east Asian eyesBr J Ophthalmol841255911049950
   PubMed Web of Science ®Google Scholar
• NordmannJP2000Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study GroupBr J Ophthalmol84181510655195
   PubMed Web of Science ®Google Scholar
• O’DonoghueEP2000A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study GroupBr J Ophthalmol845798210837379
   PubMed Web of Science ®Google Scholar
• OcklindA1998Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sectionsExp Eye Res67179919733584
   PubMed Web of Science ®Google Scholar
• PatelSS1996Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertensionDrugs Aging9363788922563
   PubMed Web of Science ®Google Scholar
• PayetS2008Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in FranceClin Drug Investig2818398
   Web of Science ®Google Scholar
• PerryMP2003Latanoprost. An update of its use in glaucoma and ocular hypertensionDrugs Aging2059763012795627
   PubMed Web of Science ®Google Scholar
• PfeifferN2002A comparison of the fixed combination of latanoprost and timolol with its individual componentsGraefes Arch Clin Exp Ophthalmol240893912486510
   PubMed Web of Science ®Google Scholar
• PillunatLE2003Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucomaBr J Ophthalmol871492614660460
   PubMed Web of Science ®Google Scholar
• QuarantaL2006Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucomaInvest Ophthalmol Vis Sci4729172316799034
   PubMed Web of Science ®Google Scholar
• QuarantaL2008aEffects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucomaInvest Ophthalmol Vis Sci4942263118502991
   PubMed Web of Science ®Google Scholar
• QuarantaLPizzolanteTRivaI2008bTwenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucomaBr J Ophthalmol9212273118586898
   PubMed Web of Science ®Google Scholar
• QuarantaL1994The effect of increased intraocular pressure on pulsatile ocular blood flow in low tension glaucomaSurv Ophthalmol38SupplS17781 discussion S1827940140
   PubMedGoogle Scholar
• QuigleyHA1996Number of people with glaucoma worldwideBr J Ophthalmol80389938695555
   PubMed Web of Science ®Google Scholar
• QuigleyHA2001The prevalence of glaucoma in a population-based of Hispanic subjects. Proyecto VERArch Ophthalmol11918192611735794
   PubMed Web of Science ®Google Scholar
• ReissGR1984Aqueous humor flow during sleepInvest Ophthalmol Vis Sci2577686724850
   PubMed Web of Science ®Google Scholar
• SakaiH2005Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patientsJ Ocul Pharmacol Ther21483916386090
   PubMed Web of Science ®Google Scholar
• SchererWJ2000Effect of latanoprost on intraocular pressure in steroid-induced glaucomaJ Glaucoma91798210782629
   PubMed Web of Science ®Google Scholar
• SharifNA2003Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analoguesInvest Ophthalmol Vis Sci447152112556403
   PubMed Web of Science ®Google Scholar
• ShayaFT2002Discontinuation rates of topical glaucoma medications in a managed care populationAm J Manag Care810 SupplS271712188170
   PubMed Web of Science ®Google Scholar
• SimmonsST2004Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trialsAdv Ther212476215605619
   PubMed Web of Science ®Google Scholar
• SmithSL1999Latanoprost 0.005% and anterior segment uveitisActa Ophthalmol Scand776687210634560
   PubMedGoogle Scholar
• SpoonerJJ2002Rates of discontinuation and change of glaucoma therapy in a managed care settingAm J Manag Care810 SupplS2627012188169
   PubMed Web of Science ®Google Scholar
• StewartWC2007Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic modelEye Aug 24 [Epub ahead of print]
   Google Scholar
• SusannaRJr2001The pros and cons of different prostanoids in the medical management of glaucomaCurr Opin Ophthalmol121495611224723
   PubMed Web of Science ®Google Scholar
• TorisCB2002Latanoprost and cholinergic agonists in combinationSurv Ophthalmol47Suppl 1S141712204711
   PubMed Web of Science ®Google Scholar
• Van der ValkR2005Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trialsOphthalmology11211778515921747
   PubMed Web of Science ®Google Scholar
• VetrugnoM1998Latanoprost 0.005% in POAG: effects on IOP and ocular blood flowActa Ophthalmol Scand Suppl2274019972341
   PubMedGoogle Scholar
• VetrugnoM2000A randomized, comparative open-label study on the efficacy of latanoprost and timolol in steroid induced ocular hypertension after photorefractive keratectomyEur J Ophthalmol102051111071027
   PubMed Web of Science ®Google Scholar
• WandM2001Latanoprost and periocular skin color changesArch Ophthalmol119614511296032
   PubMed Web of Science ®Google Scholar
• WebersCA2007Intraocular pressure–lowering effect of adding dorzolamide or latanoprost to timolol. a meta-analysis of randomized clinical trialsOphthalmology11440617070584
   PubMed Web of Science ®Google Scholar
• WensorMD1998The prevalence of glaucoma in the Melbourne visual impairment projectOphthalmology10573399544649
   PubMed Web of Science ®Google Scholar
• WistrandPJ1997The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye colorSurv Ophthalmol41Suppl 2S129389154289
   PubMed Web of Science ®Google Scholar
• ZeitzO2005Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamideBMC Ophthalmol5615811188
   PubMedGoogle Scholar